Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Accrued Liabilities
Charles River Laboratories International Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Accrued Liabilities
$380.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accrued Liabilities
$4.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
Danaher Corp
NYSE:DHR
|
Accrued Liabilities
$2.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accrued Liabilities
$319.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
Accrued Liabilities
$544m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Charles River Laboratories International Inc's Accrued Liabilities?
Accrued Liabilities
380.5m
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Accrued Liabilities amounts to 380.5m USD.
What is Charles River Laboratories International Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
13%
Over the last year, the Accrued Liabilities growth was -4%. The average annual Accrued Liabilities growth rates for Charles River Laboratories International Inc have been -1% over the past three years , 13% over the past five years , and 13% over the past ten years .